← Back to Search

Living Donor Navigation for Kidney Disease (PILOT Trial)

N/A

Waitlist Available

Research Sponsored by University of Alabama at Birmingham

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Candidates must be English-speaking or deaf with an interpreter.

Be older than 18 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up within 3 months of condition

Awards & highlights

PILOT Trial Summary

This trial will compare the effectiveness of a tele-health model for liver transplantation to the standard of care.

Who is the study for?

This trial is for adults over 18 with end-stage kidney disease who are evaluating their options for a kidney transplant. It's open to English speakers, including deaf individuals with interpreters. People unwilling to consider living donors or those under 18 cannot participate.Check my eligibility

What is being tested?

The study tests if a Living Donor Navigator Program delivered via tele-health can increase living kidney donations compared to standard care. Participants will be randomly assigned to receive the program immediately or after a delay.See study design

What are the potential side effects?

Since this trial involves a support program rather than medication, traditional side effects aren't expected. However, participants may experience emotional or psychological impacts from discussing living donation.

PILOT Trial Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Select...

I speak English or am deaf and have an interpreter.

PILOT Trial Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ within 3 months of condition

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~within 3 months of condition

This trial's timeline: 3 weeks for screening, Varies for treatment, and within 3 months of condition for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Number Live Donor Screenings

Number of Live Donor Approvals

PILOT Trial Design

2Treatment groups

Active Control

Group I: Living Donor Navigator Program In-personActive Control1 Intervention

The LDN program is designed to help transplant candidates find potential donors, and guide potential living donors through the evaluation/ donation process. The LDN program consists of four educational sessions, with each session building on the last. Each educational session lasts approximately 2 hours and is held once every other week for two months. Each LDN session will be conducted by a living donor navigator. As potential living donors are identified, the living donor navigators will work closely with the potential donors to guide them through each step of the evaluation/donation process to ensure streamlined medical services and a personalized experience. Individuals randomized to LDN in-person will receive the program locally at the transplant center.

Group II: Living Donor Navigator Program Tele-healthActive Control1 Intervention

The LDN program is designed to help transplant candidates find potential donors, and guide potential living donors through the evaluation/ donation process. The LDN program consists of four educational sessions, with each session building on the last. Each educational session lasts approximately 2 hours and is held once every other week for two months. Each LDN session will be conducted by a living donor navigator. As potential living donors are identified, the living donor navigators will work closely with the potential donors to guide them through each step of the evaluation/donation process to ensure streamlined medical services and a personalized experience. Individuals randomized to LDN tele-health will receive the program virtually at a local health department within the Alabama Department of Public Health's tele-health network.

0 / 1Eligibility criteria met

Find a Location

Who is running the clinical trial?

University of Alabama at BirminghamLead Sponsor

1,589 Previous Clinical Trials

2,279,914 Total Patients Enrolled

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)NIH

2,359 Previous Clinical Trials

4,315,055 Total Patients Enrolled

Media Library

Living Donor Navigator Program Clinical Trial Eligibility Overview. Trial Name: NCT05468463 — N/A

Kidney Disease Research Study Groups: Living Donor Navigator Program In-person, Living Donor Navigator Program Tele-health

Kidney Disease Clinical Trial 2023: Living Donor Navigator Program Highlights & Side Effects. Trial Name: NCT05468463 — N/A

Living Donor Navigator Program 2023 Treatment Timeline for Medical Study. Trial Name: NCT05468463 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Does this investigation allow for the participation of individuals in its study?

"Contrary to expectations, the information hosted on clinicaltrials.gov indicates that this trial is not currently accepting patients; its initial posting was made on January 1st 2023 and it last underwent an edit in November 15th 2022. However, there are 480 other medical studies actively recruiting individuals at present."

Answered by AI

Recent research and studies

clinicaltrials.govStudy

Promoting Increases in Living Donation Via Tele-navigation (PILOT)

Jayme E Locke 2023. "Promoting Increases in Living Donation Via Tele-navigation (PILOT)". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT05468463.